KyungDong Pharm Co., Ltd. will launch the muscle relaxant ‘Epen sustained-release tablet’ in March 2020.
‘Epen extended-release tablet’ is a treatment for painful muscle spasms accompanying musculoskeletal diseases. The biggest advantage is that it reduces the number of doses by improving the existing immediate-release tablet into a sustained-release tablet.
By increasing the dosage of the main ingredient, eperisone hydrochloride, to 75mg, the recommended daily dose of 150mg of the same ingredient can be reached just by taking it twice a day compared to the immediate-release tablet taken three times a day.
Eperisone hydrochloride is mainly used in combination with NSAIDs, which are taken twice a day, and the new product ‘Epen sustained-release tablet’ is expected to greatly increase the convenience of taking it for patients receiving a combination prescription of the two drugs.
We hope that the new product ‘EPEN extended-release tablet’, which has improved ease of administration, will help improve the symptoms of patients with musculoskeletal diseases.
♤ Product Information ♤
|
Product Name |
Epen extended-release tablets |
|
Ingredient content |
Eperisone hydrochloride 75mg |
|
Indications |
Painful muscle spasms accompanying musculoskeletal disorders: Cervical shoulder syndrome, periarthritis, back pain |
|
Dosage and usage |
This medicine is an extended-release tablet, so take it whole without crushing, splitting, or chewing. Adults: Administer orally twice a day, 1 tablet (75 mg as eperisone hydrochloride) after meals. Increase or decrease appropriately depending on age and symptoms. |
|
Reimbursement Prices |
190 won/tablet |
|
Reimbursement Code |
648104410 |
|
Packaging unit |
30 tablets/bottle 500 tablets/bottle |
※ Please refer to the product manual for other details such as precautions for use.